查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539327

糖生物学市场:全球产业分析，规模，占有率，成长，趋势，预测，2024-2033年

Glycobiology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 246 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球糖生物学市场的详细研究报告。该报告对市场推动因素、趋势、机会和课题等关键市场动态进行了深入分析，提供了对市场结构的深入洞察。

主要洞察

  • 糖生物学市场规模（2024 年）：17 亿美元
  • 预测市值（2033 年）：54 亿美元
  • 全球市场成长率（2024 年至 2033 年复合年增长率）：13.7%

糖生物学市场 - 报告范围：

糖生物学市场包括对生物系统中糖链（聚醣）的结构、功能和生物学的研究和分析。糖生物学在理解各种生物过程（包括细胞讯号传导、免疫反应和疾病进展）方面发挥着重要作用。市场按应用细分，例如药物发现/开发、诊断、肿瘤学和免疫学。糖组学研究活动的增加、个人化医疗需求的成长以及聚醣分析技术的进步推动了成长。

推动市场成长的因素：

推动全球糖生物学市场有几个关键因素。对生物製药研发的日益关注以及糖生物学在药物发现和疾病诊断中的日益应用是关键的成长动力。质谱和色谱技术的进步透过实现更准确、更有效率的聚醣分析来推动市场扩张。此外，癌症和糖尿病等慢性病的盛行率不断上升，凸显了糖生物学在开发标靶疗法中的重要性，从而推动了市场成长。聚醣生物标记在早期疾病检测中的广泛使用以及对糖工程治疗应用的兴趣日益浓厚也对市场成长做出了重大贡献。

市场阻碍因素：

儘管成长前景广阔，但糖生物学市场面临着聚醣分析的复杂性以及与先进糖生物学研究工具相关的高成本相关的课题。缺乏标准化方案以及对聚醣分析专业知识的需求可能会限制小型实验室对糖生物学技术的采用，这可能会阻碍市场成长。此外，糖生物学与临床实践的整合仍处于起步阶段，这为将研究成果转化为治疗应用带来了课题。解决这些问题需要持续投资于培训和教育，并开发具有成本效益的工具和技术，使更广泛的研究人员和临床医生更容易了解糖生物学。

市场机会：

由于基于聚醣的诊断方法的日益普及以及对创新治疗解决方案的需求不断增长，该市场提供了巨大的机会。具有更高灵敏度和特异性的下一代聚醣分析工具的开发正在满足对精准医学日成长的需求。新兴经济体不断扩大的研究活动以及学术机构和生物製药公司之间不断加强的合作提供了新的市场成长管道，并使得糖生物学在疾病治疗和预防方面的新应用得以探索。战略合作伙伴关係、对尖端技术的投资以及引入基于聚醣的个人化医疗对于利用新机会和保持市场领先地位至关重要。

本报告涵盖的主要问题

  • 推动全球糖生物学市场成长的关键因素是什么？
  • 糖生物学的哪些类型和应用正在引领各领域的采用？
  • 技术进步如何影响糖生物学市场的竞争格局？
  • 谁是糖生物学市场的主要参与者？ 他们采取哪些策略来保持竞争力？
  • 全球糖生物学市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含和排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 重要成功要素

  • 产品的采用/使用情形分析
  • 产品的USP/特征
  • 最近产品认证与发售
  • 大环境分析
  • 波特分析
  • 法规情势
  • 价值链分析

第5章 市场背景

  • 宏观经济要素
  • 预测要素- 相关性及影响
  • 动态

第6章 COVID-19危机- 影响评估

  • COVID-19及影响分析
    • 各产品
    • 各酵素
    • 各应用领域
    • 各终端用户
    • 各地区
  • 2024年的市场情势

第7章 全球市场的需求(金额及规模)分析

  • 市场(金额)分析，2019～2023年
  • 市场(金额)预测，2024～2033年
    • 前一年同期比较成长趋势分析
    • 绝对的商机

第8章 各产品:全球市场分析

  • 简介/主要调查结果
  • 市场规模(金额)分析，2019～2023年
  • 市场规模(金额)分析与预测，2024～2033年
    • 设备
    • 酵素
    • 消耗品
    • 套件和试剂
  • 各产品市场魅力分析

第9章 酵素:全球市场分析

  • 简介/主要调查结果
  • 市场规模(金额)分析，2019～2023年
  • 市场规模(金额)分析与预测，2024～2033年
    • 半乳糖??
      • 岩藻糖??
      • 几丁质?
      • 乙酰氨基半乳糖??
      • 肝素?
      • PNGase F
      • 其他
    • GlcNAc转移?
      • 乙酰葡萄糖胺转移?
      • 外毒素
      • 其他
    • 岩藻糖基转移?
    • GalNAc 转移?
    • 半乳糖基转移?
    • 葡萄醣醛酸基转移?
    • 葡萄糖基转移?
    • 戊糖基转移?
    • 碳水化合物激?
    • 神经氨酸?
    • 唾液酸转移?
    • 其他
  • 各酵素市场魅力分析

第10章 各应用领域:全球市场分析

  • 简介/主要调查结果
  • 市场规模(金额)分析，2019～2023年
  • 市场规模(金额)分析与预测，2024～2033年
    • 医药品的发现与开发
    • 诊断应用
      • 肿瘤学
      • 免疫学
      • 其他
    • 产业用途
    • 治疗用途
      • 肿瘤学
      • 免疫学
      • 其他
    • 其他
  • 各应用领域的市场魅力分析

第11章 各终端用户全球市场分析

  • 简介/主要调查结果
  • 市场规模(金额)分析，2019～2023年
  • 市场规模(金额)分析与预测，2024～2033年
    • 生物医药品企业
    • 实验室
    • 医院
    • 诊断中心
    • 受託研究机构
    • 生物科技产业
    • 学术机构
    • 其他
  • 各终端用户市场魅力分析

第12章 各地区:全球市场分析

  • 简介
  • 市场规模(金额)分析，2019～2023年
  • 市场规模(金额)分析与预测，2024～2033年
    • 北美
    • 南美
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东及非洲(中东·非洲)
  • 各地区市场的魅力分析

第13章 北美市场分析

第14章 南美市场分析

第15章 欧洲市场分析

第16章 南亚市场分析

第17章 东亚市场分析

第18章 大洋洲市场分析

第19章 中东·非洲市场分析

第20章 市场结构分析

  • 各级企业市场分析
  • 主要企业的市场占有率分析
  • 市场影响分析

第21章 竞争分析

  • 竞争仪表板
  • 品牌和推销策略
  • 主要开发分析
  • 竞争详细内容
    • Glycodiag
    • Tracxn Technologies Limited
    • Agilent Tecnologies, Inc.
    • Takara Bio Inc.
    • Bio-Techne
    • Bruker Corporation
    • Thermo Fisher Scientific Inc.
    • Shimadzu Corporation
    • New England Biolabs.
    • Waters.co.
    • Merck KGaA
    • Palleon Pharmaceuticals
    • Asparia Glycomics
    • RayBiotech Life,Inc.
    • Z Biotech,LLC.
    • Chemily Glycoscience
    • Lectenz Bio
    • 2BScientific

第22章 所使用的前提条件与缩写

第23章 调查手法

简介目录
Product Code: PMRREP4769

Persistence Market Research has recently published an in-depth report on the global Glycobiology Market. This report provides a detailed analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, offering deep insights into the market structure.

Key Insights:

  • Glycobiology Market Size (2024E): USD 1.7 Bn
  • Projected Market Value (2033F): USD 5.4 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.7%

Glycobiology Market - Report Scope:

The Glycobiology Market involves the study and analysis of the structure, function, and biology of carbohydrates (glycans) in biological systems. Glycobiology plays a crucial role in understanding various biological processes, including cell signaling, immune response, and disease progression. The market is segmented by application, including drug discovery and development, diagnostics, oncology, and immunology, among others. Growth is driven by increasing research activities in glycomics, the rising demand for personalized medicine, and advancements in glycan analysis technologies.

Market Growth Drivers:

Several key factors are driving the global Glycobiology Market. The rising focus on research and development in biopharmaceuticals and the increasing application of glycobiology in drug discovery and disease diagnosis are major growth drivers. The ongoing advancements in mass spectrometry and chromatography technologies further fuel market expansion by enabling more accurate and efficient glycan analysis. Additionally, the growing prevalence of chronic diseases, such as cancer and diabetes, underscores the importance of glycobiology in developing targeted therapies, thereby boosting market growth. The expanding use of glycan biomarkers in early disease detection and the growing interest in glyco-engineering for therapeutic applications also contribute significantly to the market's growth.

Market Restraints:

Despite the promising growth prospects, the Glycobiology Market faces challenges related to the complexity of glycan analysis and the high costs associated with advanced glycobiology research tools. The market growth may be hindered by the lack of standardized protocols and the need for specialized expertise in glycan analysis, which can limit the adoption of glycobiology technologies in smaller research institutions. Additionally, the integration of glycobiology into clinical practice is still in its nascent stages, posing challenges in translating research findings into therapeutic applications. Addressing these issues requires ongoing investment in training and education, as well as the development of cost-effective tools and techniques to make glycobiology more accessible to a broader range of researchers and clinicians.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of glycan-based diagnostics and the rising demand for innovative therapeutic solutions. The development of next-generation glycan analysis tools with higher sensitivity and specificity caters to the growing need for precision medicine. The expansion of research activities in emerging economies and the increasing collaboration between academic institutions and biopharmaceutical companies provide new channels for market growth, allowing for the exploration of novel applications of glycobiology in disease treatment and prevention. Strategic partnerships, investments in cutting-edge technologies, and the introduction of glycan-based personalized medicine are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Glycobiology Market globally?
  • Which types and applications of glycobiology are leading the adoption in various sectors?
  • How are technological advancements influencing the competitive landscape of the Glycobiology Market?
  • Who are the key players in the Glycobiology Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Glycobiology Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Glycobiology Market, including Thermo Fisher Scientific, Agilent Technologies, and Merck KGaA, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest heavily in R&D to develop advanced glycobiology tools and explore new applications in drug development and diagnostics. Collaborations with academic institutions, research organizations, and biotechnology firms facilitate market access and promote the adoption of new technologies. Emphasis on customer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Glycobiology Market landscape.

Key Companies Profiled:

  • Glycodiag
  • Tracxn Technologies Limited
  • Agilent Tecnologies, Inc.
  • Takara Bio Inc.
  • Bio-Techne
  • Bruker Corporation
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • New England Biolabs.
  • Waters.co.
  • Merck KGaA
  • Palleon Pharmaceuticals
  • Asparia Glycomics
  • RayBiotech Life,Inc.
  • Z Biotech,LLC.
  • Chemily Glycoscience
  • Lectenz Bio
  • 2BScientific

Glycobiology Market Industry Segmentation

Product:

  • Instruments
  • Enzymes
  • Consumables
  • Kits and Reagents

By Enzyme:

  • Galactosidases
  • GlcNAc Transferases
  • Fucosyltransferases
  • GalNAc Transferases
  • Galactosyl Transferases
  • Glucuronosyltransferases
  • Glucosyltransferases
  • Pentosyltransferases
  • Carbohydrate Kinases
  • Neuraminidases
  • Sialyltransferases
  • Others

Application:

  • Drug Discovery and Development
  • Diagnostic Applications
  • Industrial Applications
  • Therapeutic Applications
  • Others

End User:

  • Biopharmaceutical Companies
  • Research Laboratories
  • Hospitals
  • Diagnostic Centers
  • Contract Research Organizations
  • Biotechnology Industries
  • Academic Institutes
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Scenario
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Enzymes Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Geriatric Population
    • 5.2.2. Funding Through Government Bodies
    • 5.2.3. Technological Advancements
    • 5.2.4. Mergers and Acquisitions
    • 5.2.5. Cost of Glycobiology Products
    • 5.2.6. Increasing Incidence of Congenital Disorders
    • 5.2.7. Growing Investments in Precision Medicine Development
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Enzyme
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Instruments
    • 8.3.2. Enzymes
    • 8.3.3. Consumables
    • 8.3.4. Kits and Reagents
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Enzyme

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Enzyme, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Enzyme, 2024-2033
    • 9.3.1. Galactosidases
      • 9.3.1.1. Fucosidases
      • 9.3.1.2. Chitinases
      • 9.3.1.3. Acetylgalactosaminidase
      • 9.3.1.4. Heparinase
      • 9.3.1.5. PNGase F
      • 9.3.1.6. Others
    • 9.3.2. GlcNAc Transferases
      • 9.3.2.1. Acetylglucosaminyltransferase
      • 9.3.2.2. Exostosin
      • 9.3.2.3. Others
    • 9.3.3. Fucosyltransferases
    • 9.3.4. GalNAc Transferases
    • 9.3.5. Galactosyl Transferases
    • 9.3.6. Glucuronosyltransferases
    • 9.3.7. Glucosyltransferases
    • 9.3.8. Pentosyltransferases
    • 9.3.9. Carbohydrate Kinases
    • 9.3.10. Neuraminidases
    • 9.3.11. Sialyltransferases
    • 9.3.12. Others
  • 9.4. Market Attractiveness Analysis By Enzyme

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. Drug Discovery and Development
    • 10.3.2. Diagnostic Applications
      • 10.3.2.1. Oncology
      • 10.3.2.2. Immunology
      • 10.3.2.3. Others
    • 10.3.3. Industrial Applications
    • 10.3.4. Therapeutic Applications
      • 10.3.4.1. Oncology
      • 10.3.4.2. Immunology
      • 10.3.4.3. Others
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Biopharmaceutical Companies
    • 11.3.2. Research Laboratories
    • 11.3.3. Hospitals
    • 11.3.4. Diagnostic Centres
    • 11.3.5. Contract Research Organizations
    • 11.3.6. Biotechnology Industries
    • 11.3.7. Academic Institutes
    • 11.3.8. Others
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Enzyme
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Enzyme
    • 13.4.4. By Application
    • 13.4.5. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. U.S. Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By Enzyme
        • 13.5.1.2.3. By Application
        • 13.5.1.2.4. By End User
    • 13.5.2. Canada Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By Enzyme
        • 13.5.2.2.3. By Application
        • 13.5.2.2.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Enzyme
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Enzyme
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Brazil Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Enzyme
        • 14.5.1.2.3. By Application
        • 14.5.1.2.4. By End User
    • 14.5.2. Mexico Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Enzyme
        • 14.5.2.2.3. By Application
        • 14.5.2.2.4. By End User
    • 14.5.3. Argentina Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By Enzyme
        • 14.5.3.2.3. By Application
        • 14.5.3.2.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Italy
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. Russia
      • 15.3.1.7. BENELUX
      • 15.3.1.8. Nordic Countries
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Enzyme
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Enzyme
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Germany Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Enzyme
        • 15.5.1.2.3. By Application
        • 15.5.1.2.4. By End User
    • 15.5.2. France Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Enzyme
        • 15.5.2.2.3. By Application
        • 15.5.2.2.4. By End User
    • 15.5.3. Italy Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Enzyme
        • 15.5.3.2.3. By Application
        • 15.5.3.2.4. By End User
    • 15.5.4. U.K. Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Product
        • 15.5.4.2.2. By Enzyme
        • 15.5.4.2.3. By Application
        • 15.5.4.2.4. By End User
    • 15.5.5. Spain Market Analysis
      • 15.5.5.1. Introduction
      • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.5.2.1. By Product
        • 15.5.5.2.2. By Enzyme
        • 15.5.5.2.3. By Application
        • 15.5.5.2.4. By End User
    • 15.5.6. Russia Market Analysis
      • 15.5.6.1. Introduction
      • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.6.2.1. By Product
        • 15.5.6.2.2. By Enzyme
        • 15.5.6.2.3. By Application
        • 15.5.6.2.4. By End User
    • 15.5.7. Nordic Countries Market Analysis
      • 15.5.7.1. Introduction
      • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.7.2.1. By Product
        • 15.5.7.2.2. By Enzyme
        • 15.5.7.2.3. By Application
        • 15.5.7.2.4. By End User
    • 15.5.8. BENELUX Market Analysis
      • 15.5.8.1. Introduction
      • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.8.2.1. By Product
        • 15.5.8.2.2. By Enzyme
        • 15.5.8.2.3. By Application
        • 15.5.8.2.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Thailand
      • 16.3.1.3. Indonesia
      • 16.3.1.4. Malaysia
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Enzyme
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Enzyme
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. India Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Enzyme
        • 16.5.1.2.3. By Application
        • 16.5.1.2.4. By End User
    • 16.5.2. Thailand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Enzyme
        • 16.5.2.2.3. By Application
        • 16.5.2.2.4. By End User
    • 16.5.3. Indonesia Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Product
        • 16.5.3.2.2. By Enzyme
        • 16.5.3.2.3. By Application
        • 16.5.3.2.4. By End User
    • 16.5.4. Malaysia Market Analysis
      • 16.5.4.1. Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Product
        • 16.5.4.2.2. By Enzyme
        • 16.5.4.2.3. By Application
        • 16.5.4.2.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Enzyme
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Enzyme
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. China Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Enzyme
        • 17.5.1.2.3. By Application
        • 17.5.1.2.4. By End User
    • 17.5.2. Japan Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Enzyme
        • 17.5.2.2.3. By Application
        • 17.5.2.2.4. By End User
    • 17.5.3. South Korea Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Enzyme
        • 17.5.3.2.3. By Application
        • 17.5.3.2.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Enzyme
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Enzyme
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. Australia Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product
        • 18.5.1.2.2. By Enzyme
        • 18.5.1.2.3. By Application
        • 18.5.1.2.4. By End User
    • 18.5.2. New Zealand Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product
        • 18.5.2.2.2. By Enzyme
        • 18.5.2.2.3. By Application
        • 18.5.2.2.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Northern Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Enzyme
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Enzyme
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. GCC Countries Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product
        • 19.5.1.2.2. By Enzyme
        • 19.5.1.2.3. By Application
        • 19.5.1.2.4. By End User
    • 19.5.2. Turkiye Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product
        • 19.5.2.2.2. By Enzyme
        • 19.5.2.2.3. By Application
        • 19.5.2.2.4. By End User
    • 19.5.3. Northern Africa Market Analysis
      • 19.5.3.1. Introduction
      • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.3.2.1. By Product
        • 19.5.3.2.2. By Enzyme
        • 19.5.3.2.3. By Application
        • 19.5.3.2.4. By End User
    • 19.5.4. South Africa Market Analysis
      • 19.5.4.1. Introduction
      • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.4.2.1. By Product
        • 19.5.4.2.2. By Enzyme
        • 19.5.4.2.3. By Application
        • 19.5.4.2.4. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Branding and Promotional Strategies
  • 21.3. Key Development Analysis
  • 21.4. Competition Deep Dive
    • 21.4.1. Glycodiag
      • 21.4.1.1. Overview
      • 21.4.1.2. Product Portfolio
      • 21.4.1.3. Key Financials
      • 21.4.1.4. Sales Footprint
      • 21.4.1.5. SWOT Analysis
      • 21.4.1.6. Strategy Overview
    • 21.4.2. Tracxn Technologies Limited
      • 21.4.2.1. Overview
      • 21.4.2.2. Product Portfolio
      • 21.4.2.3. Key Financials
      • 21.4.2.4. Sales Footprint
      • 21.4.2.5. SWOT Analysis
      • 21.4.2.6. Strategy Overview
    • 21.4.3. Agilent Tecnologies, Inc.
      • 21.4.3.1. Overview
      • 21.4.3.2. Product Portfolio
      • 21.4.3.3. Key Financials
      • 21.4.3.4. Sales Footprint
      • 21.4.3.5. SWOT Analysis
      • 21.4.3.6. Strategy Overview
    • 21.4.4. Takara Bio Inc.
      • 21.4.4.1. Overview
      • 21.4.4.2. Product Portfolio
      • 21.4.4.3. Key Financials
      • 21.4.4.4. Sales Footprint
      • 21.4.4.5. SWOT Analysis
      • 21.4.4.6. Strategy Overview
    • 21.4.5. Bio-Techne
      • 21.4.5.1. Overview
      • 21.4.5.2. Product Portfolio
      • 21.4.5.3. Key Financials
      • 21.4.5.4. Sales Footprint
      • 21.4.5.5. SWOT Analysis
      • 21.4.5.6. Strategy Overview
    • 21.4.6. Bruker Corporation
      • 21.4.6.1. Overview
      • 21.4.6.2. Product Portfolio
      • 21.4.6.3. Key Financials
      • 21.4.6.4. Sales Footprint
      • 21.4.6.5. SWOT Analysis
      • 21.4.6.6. Strategy Overview
    • 21.4.7. Thermo Fisher Scientific Inc.
      • 21.4.7.1. Overview
      • 21.4.7.2. Product Portfolio
      • 21.4.7.3. Key Financials
      • 21.4.7.4. Sales Footprint
      • 21.4.7.5. SWOT Analysis
      • 21.4.7.6. Strategy Overview
    • 21.4.8. Shimadzu Corporation
      • 21.4.8.1. Overview
      • 21.4.8.2. Product Portfolio
      • 21.4.8.3. Key Financials
      • 21.4.8.4. Sales Footprint
      • 21.4.8.5. SWOT Analysis
      • 21.4.8.6. Strategy Overview
    • 21.4.9. New England Biolabs.
      • 21.4.9.1. Overview
      • 21.4.9.2. Product Portfolio
      • 21.4.9.3. Key Financials
      • 21.4.9.4. Sales Footprint
      • 21.4.9.5. SWOT Analysis
      • 21.4.9.6. Strategy Overview
    • 21.4.10. Waters.co.
      • 21.4.10.1. Overview
      • 21.4.10.2. Product Portfolio
      • 21.4.10.3. Key Financials
      • 21.4.10.4. Sales Footprint
      • 21.4.10.5. SWOT Analysis
      • 21.4.10.6. Strategy Overview
    • 21.4.11. Merck KGaA
      • 21.4.11.1. Overview
      • 21.4.11.2. Product Portfolio
      • 21.4.11.3. Key Financials
      • 21.4.11.4. Sales Footprint
      • 21.4.11.5. SWOT Analysis
      • 21.4.11.6. Strategy Overview
    • 21.4.12. Palleon Pharmaceuticals
      • 21.4.12.1. Overview
      • 21.4.12.2. Product Portfolio
      • 21.4.12.3. Key Financials
      • 21.4.12.4. Sales Footprint
      • 21.4.12.5. SWOT Analysis
      • 21.4.12.6. Strategy Overview
    • 21.4.13. Asparia Glycomics
      • 21.4.13.1. Overview
      • 21.4.13.2. Product Portfolio
      • 21.4.13.3. Key Financials
      • 21.4.13.4. Sales Footprint
      • 21.4.13.5. SWOT Analysis
      • 21.4.13.6. Strategy Overview
    • 21.4.14. RayBiotech Life,Inc.
      • 21.4.14.1. Overview
      • 21.4.14.2. Product Portfolio
      • 21.4.14.3. Key Financials
      • 21.4.14.4. Sales Footprint
      • 21.4.14.5. SWOT Analysis
      • 21.4.14.6. Strategy Overview
    • 21.4.15. Z Biotech,LLC.
      • 21.4.15.1. Overview
      • 21.4.15.2. Product Portfolio
      • 21.4.15.3. Key Financials
      • 21.4.15.4. Sales Footprint
      • 21.4.15.5. SWOT Analysis
      • 21.4.15.6. Strategy Overview
    • 21.4.16. Chemily Glycoscience
      • 21.4.16.1. Overview
      • 21.4.16.2. Product Portfolio
      • 21.4.16.3. Key Financials
      • 21.4.16.4. Sales Footprint
      • 21.4.16.5. SWOT Analysis
      • 21.4.16.6. Strategy Overview
    • 21.4.17. Lectenz Bio
      • 21.4.17.1. Overview
      • 21.4.17.2. Product Portfolio
      • 21.4.17.3. Key Financials
      • 21.4.17.4. Sales Footprint
      • 21.4.17.5. SWOT Analysis
      • 21.4.17.6. Strategy Overview
    • 21.4.18. 2BScientific
      • 21.4.18.1. Overview
      • 21.4.18.2. Product Portfolio
      • 21.4.18.3. Key Financials
      • 21.4.18.4. Sales Footprint
      • 21.4.18.5. SWOT Analysis
      • 21.4.18.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology